Bionano Genomics Inc

NASDAQ: BNGO    
Share price (5/17/24): $1.14    
Market cap (5/17/24): $76.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 4 pages Amendment to Initial Registered Note
12/34/56
EX-10.1
from 8-K 5 pages February 27, 2024 Bionano Genomics, Inc. 9540 Towne Centre Drive, Suite 100 San Diego, Ca 92121 Attn: R. Erik Holmlin Re: Agreement to Redeem Senior Secured Convertible Notes Due 2025 to the Addressees Set Forth Above
12/34/56
EX-10.2
from 10-Q 14 pages August 13, 2023 Christopher Stewart Re: Transition, Separation, and Consulting Agreement Dear Chris: This Letter Sets Forth the Substance of the Separation and Consulting Agreement (The “Agreement”) That Bionano Genomics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.1
from 10-Q 12 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 74 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 1 to Sales Agreement March 9, 2023
12/34/56
EX-10.1
from 8-K 9 pages Purchase Agreement
12/34/56
EX-10.22A
from 10-K 5 pages Amendment № 1 to the Amended and Restated Exclusive License Agreement Effective the 16th Day of July 2021 Between Stanford University and Purigen Biosystems, Inc
12/34/56
EX-10.22
from 10-K 27 pages Amended and Restated Exclusive License Agreement With Equity
12/34/56
EX-10.14A
from 10-K 3 pages First Amendment to Lease
12/34/56
EX-10.14
from 10-K 40 pages Lease 5700 Stoneridge Drive Pleasanton, California Basic Lease Information
12/34/56
EX-10.2C
from 10-K 13 pages Bionano Genomics, Inc. Stock Option Grant Notice
12/34/56
EX-10.2B
from 10-K 12 pages Bionano Genomics, Inc. Stock Option Grant Notice
12/34/56
EX-10.2A
from 10-K 11 pages Bionano Genomics, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 8-K 25 pages Bionano Genomics, Inc. 2020 Inducement Plan Adopted by the Board of Directors: August 20, 2020 Amended by the Board of Directors: October 6, 2021 Amended by the Board of Directors: November 23, 2022
12/34/56
EX-10.39
from 10-K 7 pages Fifth Amendment
12/34/56
EX-10.38
from 10-K 19 pages Commercial Single-Tenant Lease -- Net 1. Basic Provisions (“Basic Provisions”). 1.1 Parties: This Lease (“Lease”), Dated for Reference Purposes Only, Is Made by and Between Tesa Beach, LLC (“Lessor”) and Biodiscovery, Inc. (“Lessee”), (Collectively the “Parties,” or Individually a “Party”)
12/34/56
EX-10.36
from 10-K 12 pages Employment Agreement
12/34/56
EX-10.35
from 10-K 13 pages Stock Restriction Agreement
12/34/56